Results 21 to 30 of about 48,636 (289)

Pharmacogenetics of Anticoagulants [PDF]

open access: yesHuman Genomics and Proteomics, 2010
Warfarin, acenocoumarol, and phenprocoumon are among the major anticoagulant drugs worldwide. Because of their low therapeutic index and serious adverse reactions (ADRs), their wide use, and their varying kinetics and pharmacogenetic dependence, it is of great importance to explore further possibilities to forecast the dose beyond conventional INR ...
Anders Rane, Jonatan D. Lindh
openaire   +3 more sources

Comparative evaluation of mineral profiles in different blood specimens of dairy cows at different production phases

open access: yesFrontiers in Veterinary Science, 2022
BackgroundEvaluation of mineral profiles including essential and toxic elements in dairy cows provides fundamental information for bovine practitioners during regular herd supervision and monitoring.
Hussein Awad Hussein   +2 more
doaj   +1 more source

Anticoagulation in cirrhosis [PDF]

open access: yesLiver International, 2012
The Authors review and comment a recent publication by Senzolo et al.
VILLA, Erica, N. De Maria
openaire   +4 more sources

Complications of Pharmacotherapy with New Oral Anticoagulants Caused by Inter-Drug Interactions: Focus on Gastrointestinal Bleeding

open access: yesБезопасность и риск фармакотерапии, 2019
New oral  anticoagulants are  effective for  the  prevention of thromboembolic complications in patients with atrial fibrillation, or after orthopedic surgery.
A. P. Pereverzev   +3 more
doaj   +1 more source

Prediction of need for bowel resection in acute superior mesenteric artery occlusion: A retrospective study of 48 Japanese patients

open access: yesAnnals of Gastroenterological Surgery, Volume 7, Issue 1, Page 175-181, January 2023., 2023
In a study of 48 patients with acute superior mesenteric artery occlusion, a logistic regression model using time from onset to diagnosis and the occlusion site of superior mesenteric artery showed 78.6% sensitivity in ruling out cases requiring bowel resection.
Susumu Watada   +9 more
wiley   +1 more source

The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents

open access: yesTH Open, 2020
SARS-CoV-2 infection (COVID-19) results in local and systemic activation of inflammation and coagulation. In this review article, we will discuss the potential role of coagulation factor Xa (FXa) in the pathophysiology of COVID-19. FXa, a serine protease,
Galit H. Frydman   +3 more
doaj   +1 more source

Anticoagulants [PDF]

open access: yesBritish Medical Bulletin, 2000
Anticoagulation is a treatment with significant and life threatening complications requiring that the balance of risk and benefit be individually assessed in each patient. The risks are greater in the elderly and those with hypertension, falls and gastrointestinal disease.
openaire   +2 more sources

Serological Parameters and Vascular Investigation for a Better Assessment in DVT during Pregnancy—A Systematic Review

open access: yesMedicina, 2021
Pregnancy and the postpartum period represent a condition characterized by a thrombotic predisposition. The majority of pregnant women do not face acute or severe thrombotic events.
Catalina Filip   +5 more
doaj   +1 more source

Review of Medical Therapies for the Management of Pulmonary Embolism

open access: yesMedicina, 2021
Traditionally, the management of patients with pulmonary embolism has been accomplished with anticoagulant treatment with parenteral heparins and oral vitamin K antagonists.
Ladan Panahi   +7 more
doaj   +1 more source

Cost‐effectiveness of second‐line therapies in adults with chronic immune thrombocytopenia

open access: yesAmerican Journal of Hematology, Volume 98, Issue 1, Page 122-130, January 2023., 2023
Abstract Major options for second‐line therapy in adults with chronic immune thrombocytopenia (ITP) include splenectomy, rituximab, and thrombopoietin receptor agonists (TRAs). The American Society of Hematology guidelines recommend rituximab over splenectomy, TRAs over rituximab, and splenectomy or TRAs while noting a lack of evidence on the cost ...
George Goshua   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy